Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The caspase family comprises cysteine-dependent aspartate-directed proteolytic enzymes that play central roles in programmed cell death (apoptosis) and inflammation. They are synthesized as inactive zymogens containing prodomains with structural motifs from the death domain superfamily—including CARD and DED domains—which mediate recruitment into signaling complexes. Upon activation by cleavage at specific sites, they form active heterotetramers that execute cellular demolition by cleaving key substrates at C-terminal aspartic acid residues[2]. The family is subdivided into initiator/inflammatory and effector/apoptotic groups based on their function. Dysregulation of individual caspases has been implicated in diseases such as cancer, neurodegeneration, and inflammatory disorders[1][2][3]. Note: For structured data applications or drug discovery purposes, it is recommended to specify an individual member of the caspase family rather than using this general term[2][3].
Mechanisms include inhibition of enzymatic activity to block apoptosis or inflammation; specifics depend on the particular caspase targeted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase family protein (Caspase).